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Abstract
Background: The extended ‘hygiene hypothesis’ suggests that the initial composition of the infant gut microbiota
is a key determinant in the development of atopic disease. Several studies have demonstrated that the microbiota
of allergic and non-allergic infants are different even before the development of symptoms, with a critical time
window during the first 6 months of life. The aim of the study was to investigate the association between early
intestinal colonisation and the development of asthma in the first 3 years of life using DGGE (denaturing gradient
gel electrophoresis).
Methods: In a prospective birth cohort, 110 children were classified according to the API (Asthma Predictive
Index). A positive index included wheezing during the first three years of life combined with eczema in the child
in the first years of life or with a parental history of asthma. A fecal sample was taken at the age of 3 weeks and
analysed with DGGE using universal and genus specific primers.
Results: The Asthma Predictive Index was positive in 24/110 (22%) of the children. Using universal V3 primers a
band corresponding to a Clostridum coccoides XIVa species was significantly associated with a positive API. A
Bacteroides fragilis subgroup band was also significantly associated with a positive API. A final DGGE model,
including both bands, allowed correct classification of 73% (80/110) of the cases.
Conclusion: Fecal colonisation at age 3 weeks with either a Bacteroides fragilis subgroup or a Clostridium coccoides
subcluster XIVa species is an early indicator of possible asthma later in life. These findings need to be confirmed in
a new longitudinal follow-up study.
Keywords: DGGE infant, intestinal microbiota, asthma
Background
The increasing prevalence of asthma and other atopic
diseases during the last decades was originally explained
by the reduced exposure to infections early in life [1].
More recently Rautava et al. [2] suggested an extension
of this “hygiene hypothesis” describing the importance
of the initial composition of the infant gut microbiota as
a key determinant in the development of atopic disease.
This hypothesis is supported by studies demonstrating
that the microbiota of allergic and non-allergic infants
are different even before the development of symptoms,
with a critical time window during the first 6 months of
life [3]. The findings from these studies however are
inconsistent: 4 different bacterial genera (Staphylococcus,
Bacteroides, Clostridium, Enterobacteriaceae)a r ea s s o -
ciated with an increased risk for atopic disease and 2
genera (Bifidobacterium, Lactobacillus) show a protec-
tive effect [4]. Most studies conducted so far were cross-
sectional focusing on atopic dermatitis, only few studies
considered asthma as outcome.
Until a decade ago, most of our knowledge on the
composition of the intestinal microbiota was mainly
based on culture dependent techniques. Comparisons
with molecular methods have indicated that culture
dependent methods underestimate intestinal microbiota
diversity as only 10-50% of this population is culturable
[5]. About 400 different species inhabit the human
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sequencing more than 7000 different phylotypes were
detected in the human gut [6]. Denaturing gradient gel
electrophoresis (DGGE) is a molecular sequence depen-
dent fingerprinting technique that allows to characterize
the intestinal microbiota without pre-existing knowledge
of its composition. DGGE using universal [7] and bifido-
bacterial primers [8] based on the bacterial 16S rRNA
sequence has been applied successfully to monitor the
development of the gut microbiota in infants.
In the Asthma and Allergy study we performed DGGE
analysis of bacterial 16S rDNA genotypes on fecal sam-
ples to assess whether the intestinal microbiota of
infants at the age of 3 weeks is associated with the
development of asthma during the first 3 years of life.
Methods
The Asthma and Allergy study is a prospective birth
cohort and part of the Environmental Health action of
the Flemish Ministry of Health and Environment. Chil-
dren (n = 158) were recruited through maternity clinics
in Flanders. Selection criteria for enrolment in the study
were vaginal delivery at term and uncomplicated perina-
tal period. Questionnaires were collected with data on
the parents, including demography, smoking and
asthma. Data of the child on demography, respiratory
symptoms and risk factors for asthma were collected by
postal questionnaires sent every 6 months starting at the
age of 3 weeks until the age of 36 months. The question
on the presence of wheezing referred to the period
between two questionnaires, e.g. the presence of wheez-
ing in the questionnaire at 6 months referred to the
time period between 3 weeks and 6 months. The study
protocol was approved by the medical ethics committees
of the participating institutes. All parents gave written
informed consent.
Symptoms of wheeze were assessed by International
Study of Asthma and Allergies in Childhood core ques-
tions [9]. Information about doctor’s diagnosed parental
asthma was collected by the following question: ‘’Did a
doctor ever diagnose asthma?’’. Based on the longitudinal
questionnaire data on wheeze symptoms in the first
3 years of life, children were classified according to the
‘loose’ Asthma Predictive Index (API) into an API positive
and an API negative group. According to the ‘loose’ index
ap o s i t i v eA P Ii n c l u d e dw h e e z i n gd u r i n gt h ef i r s tt h r e e
years of life and eczema or parental history of asthma [10].
Approximately 2 g of stools was collected into a sterile
recipient by the parents at 3 weeks of age. The sample
was sent to the laboratory under anaerobic conditions
where it was stored immediately at -70°C until analysis.
DNA was extracted from fecal samples based on the
method of Pitcher et al. [11] modified by Vanhoutte
et al. [5]. A saline suspension of feces was made by
diluting 1 g of wet feces in 10 ml of sterile saline solu-
tion and homogenized using a stomacher. Of this fecal
sample suspension, 1 ml was centrifuged at 20,000 g for
5 min. After removal of the supernatant, the pellet was
resuspended in 1 ml TE buffer (10 mM Tris-HCl, 1 mM
EDTA, pH 8.0) and was again centrifuged at 20,000 g
for 5 min. The pellet was resuspended in 150 μl enzyme
solution (6 mg lysozyme powder [Serva] and 40 μl
mutanolysine [Sigma] dissolved in 110 μlT E( 1× )p e r
sample) followed by incubation at 37°C for 40 min.
Next, 500 μl GES reagent (Guanidiumthiocyanate-
EDTA-Sarkosyl; 600 g l
-1 guanidiumthiocyanate [Sigma],
200 ml l
-1 0 . 5ME D T A ,1 0gl
-1 sarkosyl) was added to
complete all lysis, after which the solution was put on
ice for 10 min. In the following step, 250 μla m m o n i u m
acetate (7.5 M) was added and the mixture was put
on ice for 10 min. Subsequently, two chloroform-iso-
amylalcohol extractions were performed with 500 μl
chloroform/iso-amylalcohol solution (24/1). Finally,
DNA was precipitated by adding 0.54 volumes of ice-
cold isopropanol. After centrifugation at 20,000 g for
5 min, the pellet was washed twice with 150 μl7 0 %
EtOH, air dried and allowed to dissolve overnight in
150 μl TE (1 ×) buffer. The remaining RNA was
removed by adding 7.5 μl RNase (2 mg ml
-1; Serva) after
which samples were incubated for 1.5 h at 37°C. Purified
DNA extracts were stored at -20°C.
PCR was performed with a Taq polymerase kit (Super-
taq, HT Biotechnology Ltd). Each PCR mixture (50 μl)
contained 6 μl 10 × PCR buffer (containing 15 mM
MgCl2), 2.5 μlB o v i n eS e r u mA l b u m i n( 0 . 1m gm l
-1),
2.5 μl dNTP preparation (containing each dNTP at a
concentration of 2 mM), 2 μlo fe a c hp r i m e r( 5μM);
0.25 μl Taq polymerase, 33.75 μl sterile Milli-Q water
and 1 μl of 10-fold diluted DNA solution. One single
PCR core program was used for all primer pairs: initial
denaturation at 94°C for 5 min; 30 cycles of denaturation
at 94°C for 20 s, annealing at primer-specific temperature
(Table 1) for 45 s and extension at 72°C for 1 min; and
final extension at 72°C for 7 min followed by cooling to
4°C. PCR amplicons were verified with electrophoresis in
a 1.5% agarose gel after staining with ethidium bromide
(50 μl in 500 ml 1 × TAE buffer [TE buffer with 5.71%
(vol/vol) acetic acid]) with a 100-bp molecular ruler
(Invitrogen) to compare with the expected amplicon size
for the corresponding primer set (table 1) (data not
shown). PCR amplification products were stored at -20°C.
16S rRNA gene amplicons were analyzed with DGGE
as described previously [12]. In our study, different types
of denaturing gradient were applied depending on the
primers used (table 1). The polyacrylamide gels (160 by
160 by 1 mm) consisted of 8% (vol/vol) polyacrylamide
(Biorad) in 1 × TAE buffer. By diluting a 100% denatur-
ing polyacrylamide solution (containing 7 M urea
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mide solution containing no denaturing components,
polyacrylamide solutions with the desired denaturing
percentages were obtained. The 24-ml gradient gels were
cast by using a gradient former (Biorad) and a pump
(Biorad) set at a constant speed of 5 ml/min. The dena-
turing gels were allowed to polymerize for 3 h, after
which a 5-ml nondenaturing stacking gel containing a
16-well comb was poured on top. After 1 h of polymeri-
zation, PCR samples were loaded into the wells, and elec-
trophoresis was performed for 16 h at 70 V in 1 × TAE
buffer at a constant temperature of 60°C by using the
Dcode system (Biorad). DGGE gels were stained for
30 min with 1 × SYBR
® Gold (Molecular Probes) in 1 ×
TAE buffer. This was followed by visualization of DGGE
band profiles under UV light. Digital capturing was per-
formed by using a Geldoc XR camera system (Biorad)
combined with the Quantity One software package
(Biorad). By including a standard reference every six
lanes in each DGGE gel, it was possible to digitally nor-
malize the gel profiles by comparison with a standard
pattern using the BioNumerics software, version 2.5
(Applied Maths, St.-Martens-Latem, Belgium). This nor-
malization enabled comparison between DGGE profiles
from different gels provided that these were run under
comparable denaturing and electrophoresis conditions.
The digitalized data were exported as an excel file for
further statistical analysis according to Gafan et al. [13].
In this file, each sample represented 1 row and each
band was assigned to a unique band position (column)
with 1 indicating presence and 0 indicating absence of a
band at that position. API was used as outcome para-
meter. The data were first analysed using Chi-square
tests with a cut-off for significance at 5% to reduce the
number of bands included in multivariate analysis. Sig-
nificant bands (absent coded as 0, present coded as 1)
were included as explanatory variables in a multivariate
logistic regression analysis (API as dependent variable,
negative coded as 0, positive as 1) for each primer set
separately. The estimated odds ratio was calculated for
each band in the logistic regression model. Bands
remaining significantly associated with the API index in
this model were adjusted for 5 known asthma confoun-
ders (exclusive breast feeding, maternal smoking during
pregnancy, infant use of antibiotics at age of 3 weeks,
parental socio-economic status and gender) in a second
logistic regression model. The statistical analysis was
conducted using SPSS version 15 (Chicago, USA).
Significant bands in this second model were identified
after excision of the band from the gel and overnight
incubation in TE buffer at 4°C. After extraction of the
band it was reamplified with the corresponding primer
set and reanalysed in DGGE together with the original
fecal sample to confirm if the correct band was
extracted. This process was repeated 2-3 times until a
single band was obtained. This band was subsequently
sequenced without additional cloning by the Genetic
Service Facility (VIB, University of Antwerp) with a
capillary sequencer (Applied Biosystems 3730 DNA ana-
lyser) using the corresponding forward and reverse pri-
mers without the GC clamp. In all cases this procedure
r e s u l t e di nap u r es e q u e n c ep r o d u c tf r o mt h ee x c i s e d
band. The obtained sequences were analysed using the
BLAST program.
Results
Description of the study population
Of the 158 children recruited in this study, 54% were
boys. Maternal or paternal asthma was present in 8%
and 5% of the children, respectively. Several children
were lost for follow-up at the end of the 3 year study
period. As a result, API at age 3 years could not be
determined in 41 of the 158 children due to missing
data on wheezing (n = 30) or on eczema (n = 9) of the
child in the 6 monthly questionnaires or on parental
asthma (n = 5). As described previously, there were no
differences in the percentage of children with wheeze at
any age, parental asthma, and eczema at any age or
Table 1 Specifications of the 16S rRNA primers used in this study
Target group (variable
region)
Primer
designation
Primer sequence (5’-3’) Amplicon
size
Annealing
temperature
DGGE
gradient
Reference
Universal (V3) F357-GC
a
518R
TACGGGAGGCAGCAG
ATTACCGCGGCTGCTGG
217 55°C 20-70% Muyzer et al.,
1993
Universal (V6-V8) U968F-GC
a
L1401-R
AACGCGAAGAACCTTAC
CGGTGTGTACAAGACCC
489 55°C 20-70% Zoetendal et al.,
1998
Bacteroides fragilis
subgroup
Bfra 531F
Bfra 766R-GC
a
ATACGGAGGATCCGAGCGTTA
CTGTTTGATACCCACACT
293 65°C 20-70% Vanhoutte et al.,
2006
Bifidobacterium g-Bifid F
g-Bifid R-GC
a
CTCCTGGAAACGGGTGG
GGTGTTCTTCCCGATATCTACA
596 65°C 40-70% Matsukiu et al.,
2002
Lactobacillus group
b Lac 1
Lac2-GC
a
AGCAGTAGGGAATCTTCCA
ATTYCACCGCTACACATG
380 61°C 35-60% Walter et al., 2001
a Primers with GC clamp at 5’ end: CGCCCGCCGCGCCCCGCGCCCGGCCCGCCGCCCCCGCCCC.
b Lactobacillus group comprising the genera Lactobacillus, Leuconostoc, Pediococcus and Weisella.
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could not be categorized according to API [14]. In 7
children insufficient fecal sample was available to per-
form a DGGE analysis. API was positive in 24/110
(22%) of the remaining children.
Fecal microorganisms in the study population
A total of 145 fecal samples were collected, which is a
response rate of 92%.
The Lactobacillus and Bifidobacterium primers did
not show any correlation with the API index (data not
shown). With the universal V6-V8 primers only 1 single
band (band 54.2) correlated significantly with the API
index (Chi square, p = 0.04). After adjustment for exclu-
sive breast feeding, maternal smoking during pregnancy,
infant use of antibiotics at age of 3 weeks, parental
socio-economic status and gender in a multivariate
logistic regression analysis, the V6-V8 band 54.2
remained significantly associated with the API index
(OR = 4.0, CI 1.2-12.9) (table 2). Excision and sequen-
cing of band 54.2 revealed a DNA fragment of 397 bp
[EMBL:FN611010] showing 98% similarity with an
uncultured bacterial sequence isolated from a human
f e c a ls a m p l e( t a b l e3 ) .T h eh ighest sequence similarity
with a known species was obtained for Eubacterium
contortum, Clostridium oroticum and Ruminococcus tor-
ques (table 3). These species belong to the Clostridium
subcluster XIVa proposed by Collins et al. [15], which
constitutes a major part of the human fecal flora [16].
With the universal V3 primers only 2 bands (band
60.1 and 95.0) correlated significantly with the API
index (Chi square, respectively p = 0.03 and p = 0.04).
In a logistic regression analysis including both bands,
only band 60.1 (OR = 5,9; CI 1,1 - 7,9) remained inde-
pendently associated with the API index (band 95.0: OR
=5 . 71 0
9; CI 0 - NA). After further adjustment for
confounders in a multivariate logistic regression analysis,
the V3 band 60.1 remained significantly associated with
the API index (table 2). Excision and sequencing of
band 60.1 revealed a DNA fragment of 139 bp [EMBL:
FN611009] showing 100% similarity with an uncultured
bacterial sequence isolated from a human fecal sample
(table 3). The highest sequence similarity with a known
species was obtained for Ruminococcus productus or
hansenii and Clostridium sp (table 3). These species also
belong to the Clostridium subcluster XIVa proposed by
Collins et al. [15] with Clostridium coccoides as their
nearest neighbour.
With the Bacteroides fragilis subgroup primers 4
bands (band 18.4; 27.3; 45.9 and 57.9) correlated signifi-
cantly with the API index (Chi square, respectively p =
0.008; 0.048; 0.006 and 0.048). In a logistic regression
analysis including all 4 bands only band 45.9 (OR = 7.1;
CI 1,1 - 46,1) remained independently associated with
the API index (band 18.4: OR = 4,8; CI 0,3 - 80,0/band
27.3: OR = 8,6 10
7; CI 0 - NA/band 57.9: OR = 8,6 10
7;
CI 0 - NA). After adjustment for confounders, the Bac-
teroides fragilis subgroup band 45.9 remained signifi-
cantly associated with the API index (table 2). Excision
and sequencing of band 45.9 revealed a DNA fragment
of 241 bp [EMBL:FN611011] showing 99% similarity
with Bacteroides fragilis (table 3). A similarity of 98 and
97% was found with respectively Bacteroides finegoldii
and Bacteroides thetaiotaomicron (table 3). In a final
logistic regression model including the 3 significant
DGGE bands only V3 band 60.1 (OR = 3,4; CI 1,2 - 9,7)
and the Bacteroides fragilis subgroup band 45.9 (OR =
9,8; CI 1,6 - 59,3) proved to be independent variables
excluding the V6-V8 band 54.2 (OR = 2,3; CI 0,7 - 7,8)
from the model. After adjustment for confounders, this
simple final DGGE model including only 2 bands (band
60.1 and band 45.9) remained significantly associated
Table 2 Multiple logistic regression analysis of risk factors for outcome variable Asthma Predictive Index at age 3 years
V6-V8 band 54.2 V3 band 60.1 BF band 45.9 Final DGGE model*
Variable OR P OR P OR P OR P
Presence of a DGGE band at the age of 3 weeks (yes versus no) 4,0 0,02 3,6 0,02 10,5 0,008 4,7 0,002
Exclusive breastfeeding age below the age of 3 weeks
(yes versus no)
1,4 0,58 1,5 0,47 1,1 0,90 1,5 0,50
Maternal smoking during pregnancy (yes versus no) 1,4 0,69 1,7 0,56 1,6 0,58 1,9 0,47
Infant use of antibiotics below the age of 3 weeks
(yes versus no)
0 1,0 0 1,0 0 1,0 0 1,0
Parental socioeconomic status (low versus high) 1,1 0,86 1,1 0,92 1,3 0,64 1,1 0,86
Infant gender (male versus female) 0,5 0,22 0,6 0,26 0,7 0,51 0,6 0,29
Odds ratios are adjusted for the independent variables, indicated in the rows of the table.
OR: adjusted odds ratio.
P: P value.
BF: Bacteroides fragilis subgroup.
* Final DGGE model: a combination of V3 band 60.1 (Clostridium coccoides subcluster XIVa) and Bacteroides fragilis subgroup band 45.9.
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asthma at the age of 3 years using this final DGGE
model is shown in table 4. The model allows correct
classification of 73% (80/110) of the cases.
This means that, according to our findings, early
intestinal colonization of infants with bacteria belonging
to the Bacteroides fragilis group and/or to the Clostri-
dium coccoides subcluster XIVa is associated with an
increased risk for the development of asthma at the age
of 3 years. These bacteria are strict anaerobes and are
part of the dominant genera of the normal intestinal
microbiota observed in adults. We could not detect any
bacterial taxa that were associated with health (API
negative status). Lactobacillus and Bifidobacterium,t h e
bacterial genera generally used as probiotics and consid-
ered by definition of having a beneficial effect on health
could not be associated with a reduced risk of asthma.
However it cannot be excluded that our inability to
demonstrate a beneficial effect of certain bacterial taxa
on infant health was caused by the limited sensitivity of
the DGGE method that we used.
Discussion
This study shows an association between early colonisa-
tion with a Bacteroides fragilis subgroup species and
asthma later in life. We also showed in this study that a
Clostridium coccoides subcluster XIVa species is an early
indicator of asthma later in life. This is the first prospec-
tive study that links Clostridium coccoides subcluster
XIVa to API, a clinically relevant risk factor for develop-
ing asthma. Differences in feeding pattern, use of anti-
biotics, gender, maternal smoking in pregnancy or
parental socio-economic status cannot explain the
findings.
Asthma is a frequently occurring condition in children
with up to 50% of infants and children suffering of one
or more episodes of wheezing below the age of 6 years.
The diagnosis of asthma is not straightforward since no
simple clinical tools are available to discriminate chil-
dren prone to develop persistent asthma from those
who will not. The ‘Asthma Prediction Index’ has been
associated with an increased risk for asthma at school
age [10]. This index was chosen as outcome parameter
for the study since it is at present the best tool for pre-
diction of asthma at school age. We used the so-called
‘loose’ index, which only required infrequent wheezing
episodes in early life combined with risk factors for
asthma because it has a much higher sensitivity (39%)
but slightly lower specificity (82%) and positive predic-
tive value (32%) than the so-called “stringent” index.
The negative predictive value at all ages was very high
for both indices, suggesting that the great majority of
Table 3 BLAST identifications of the excised DGGE bands
DGGE amplicon Identification Sequence # Bp
Band nr Primer # Bp Species Accession Nr % identity Identical Total
54.2 L1401-R
(V6-V8)
397 Uncultured bacterium EF405354.1 98 385 389
Eubacterium contortum L34615.1 93 364 390
Clostridium oroticum M59109.1 94 367 389
Ruminococcus torques L76604.1 93 365 389
60.1 518R
(V3)
139 Uncultured bacterium EF403112.1 100 124 124
Ruminococcus productus AY937379.1 98 122 124
Clostridium sp. Y10584.1 98 122 124
Ruminococcus hansenii M59114.1 97 121 124
45.9 Bfra 531F 241 Bacteroides fragilis DQ100447.1 99 210 211
Bacteroides finegoldii AB222700.1 98 207 211
Bacteroides thetaiotaomicron AY319392.1 97 206 211
Table 4 Accuracy of final DGGE model* in predicting API
status at age 3 years
API index N
Pos Neg
DGGE model Pos. 13 19 32 PPV = 41%
DGGE model Neg. 11 67 78 NPV = 86%
Total 24 86 110
54% S 78% Sp X
2, p = 0.002
Overall correct classification: 80/110 = 73%.
API prevalence: 24/110 = 22%.
Final DGGE model:
Positive: presence of band 60.1 (Clostridium coccoides subcluster XIVa) or band
45.9 (Bacteroides fragilis subgroup).
Negative: absence of band 60.1 (Clostridium coccoides subcluster XIVa) and
band 45.9 (Bacteroides fragilis subgroup).
N: number of cases.
PPV: positive predictive value.
NPV: negative predictive value.
S: sensitivity.
Sp: specificity.
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years had a negative predicted index during the first
years of life. Because the Asthma Predictive Index is
only an approximation to predict which children will
subsequently develop persistent asthma, further follow-
up at school age is required to definitely determine the
relation between early Bacteroides fragilis and Clostri-
dium coccoides subcluster XIVa colonisation and
asthma.
With the exception of our previous study [14] using
conventional culture methods, there are no data linking
the Bacteroides fragilis subgroup to asthma but several
studies showed a correlation between Bacteroides and
allergy: A higher IgG immune response to Bacteroides
vulgaris was found in high school children with allergic
symptoms [17]. A positive correlation between the fecal
counts of Bacteroides a n dt h es e r u mI g Ec o n c e n t r a t i o n
was demonstrated in 2 studies, one in infants intolerant
to an extensively hydrolysed formula [18] and one in
non-allergic children at the age of 5 years [19]. A study
in adults with pollen allergy showed an increased ratio
of fecal counts of Bacteroides fragilis to Bifidobacterium
during pollen season. In vitro, using peripheral blood
mononuclear cells of these patients, they also demon-
strated that Bacteroides fragilis strains induced more
Th2 cytokines but fewer Th1 cytokines compared with
Bifidobacterium strains [20]. We believe that intestinal
Bacteroides species might be able to induce a Th2 cyto-
kine response through binding of a TLR2 (Toll-like
receptor) present on intestinal dendritic cells. Netea
et al. showed that Bacteroides species stimulate cytokine
release through TLR2-dependent (not TLR4) mechan-
isms [21]. TLR2 agonists induce a Th2 response by sup-
pressing IL-12 production [22].
Fecal Clostridium colonisation in infants has been
linked to asthma before: A higher level of C. difficile-
specific IgG was found in one-year-old children
with recurrent wheezing [23]. A higher prevalence of
C. difficile was detected using quantitative real-time
PCR in infants who developed recurrent wheeze during
the first 2 years of life [24]. C. difficile belongs to Clos-
tridium cluster XI and is only remotely related to the
Clostridium coccoides subcluster XIVa species that we
detected [15]. These differences might be explained by
the use of different methods (DGGE versus quantitative
PCR or serology) and because different clinical out-
comes were determined (API at the age of 3 years
versus recurrent wheezing at the age of 1 or 2 years). In
adult fecal microbiota Clostridium coccoides subcluster
XIVa is the most abundant taxonomic group [16] but in
infants it normally constitutes only a subdominant
group at much lower counts [25]. Through the peptido-
glycan present in their bacterial cell membrane the
intestinal Clostridium species might be able to induce a
Th2 cytokine response by binding to the TLR2 of the
intestinal dendritic cells [21,22].
Several studies used DGGE to examine the relation-
ship between the composition of the intestinal micro-
biota and the development of allergy and eczema
[26-28]. In a case-control study, the prevalence of one
specific DGGE band (identified as E. coli) was higher in
infants with eczema [26]. A reduced fecal microbial
diversity was observed with DGGE in allergic children
[27] or in infants with eczema [28]. Only one study
looked at wheezing as outcome using DGGE but did
not find a difference in gut microbiota between wheez-
ing and non-wheezing children at the age of 3-5 years
[29]. We found a difference in the composition of the
fecal microbiota at the age of 3 weeks but not later (at
the age of 6 and 12 months; data not shown), illustrat-
ing the importance of a critical time window during the
first 6 months of life [3].
Prematurity is a much more complex situation than the
normal population observed in our study. A delay of up to
6 months of the intestinal Bacteroides colonization, which
occurs in newborns after caesarean section, might even
decrease the subsequent risk for asthma in these prema-
ture infants according to our findings. However, genetic
factors or the underlying disease that provoked the prema-
ture delivery itself might significantly increase the subse-
quent risk for asthma. Future studies on premature
newborns and their respiratory disease outcome should
not only include the intestinal microbiota but should also
correct for confounders like antibiotic use, mode of deliv-
ery and underlying disease or genetic mutations.
Despite obvious advantages, DGGE also has a limita-
tion. The detection limit of DGGE is estimated to
approach 1% of the total population or a concentration
of 10
6 CFU/g feces. This is significantly higher than the
detection limit of the culture method we used in our
previous study (detection limit ≥ 10
3 CFU/g feces) [14].
Another limitation of the present study is the fact that
no stool sample of the mother was included, so we can-
not make any statement on the origin of the Bacteroides
and Clostridium strains recovered in these infants.
Finally, as in every longitudinal study, missing data is a
problem. Since there were no differences in the percen-
tage of children with wheezing, eczema or parental
asthma or gender of the infant between children who
could or could not be categorized according to API, it
seems improbable that the missing data resulted in a
systemic bias. Adjustment for known confounders in a
multivariate logistic regression analysis further con-
firmed our findings.
Conclusions
Fecal colonisation at age 3 weeks with either a Bacter-
oides fragilis subgroup or a Clostridium coccoides
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Page 6 of 7subcluster XIVa species is an early indicator of possible
asthma later in life. These findings need to be confirmed
in a new longitudinal follow-up study. The effect of pre-
and probiotics on the intestinal colonization with Clos-
tridium and Bacteroides requires further attention in
future trials for the prevention of asthma in infants and
children.
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